Neisseria meningitides: an overview of the carriage state, J MedMicrobiol, vol.53, pp.821-853, 2004. ,
The duality of virulence and transmissibility in Neisseria meningitidis, Trends Microbiol, vol.10, issue.8, pp.376-82, 2002. ,
W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, Euro Surveill, vol.17, issue.21, p.20181, 2012. ,
, Public health management of sporadic cases of invasive meningococcal disease and their contacts, 2010.
Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin, J Infect Dis, vol.1995171, issue.3, pp.728-759 ,
Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population, J Infect Dis, vol.130, issue.3, pp.217-241, 1974. ,
Efficacy of rifampicin in treatment of meningococcal carriers, N Engl J Med, vol.281, issue.12, pp.641-646, 1969. ,
The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria, J Infect, vol.2, issue.2, pp.137-180, 1980. ,
Effect of rifampin and minocycline on meningococcal carrier rates, J Infect Dis, vol.124, issue.2, pp.199-205, 1971. ,
Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis, Clin Microbiol Infect, vol.15, pp.1178-81, 2009. ,
Rapport annuel du CNR des Méningocoques : synthèse de, 2006. ,
, on the prevention of invasive meningococcal disease, Direction Générale de la Santé. Instruction n° DGS/RI1/2011/33 du 27 janvier 2011 relative à la prophylaxie des infections invasives à méningocoque, 2011.
Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis, Lancet, vol.341, issue.8853, pp.1152-1155, 1993. ,
Rifampicin-resistant meningococcal dosease in patient given prophylactic rifampicin, J Pediatr, vol.108, issue.1, pp.93-96, 1986. ,
Secondary cases of meningococcal infection among close family and household contacts in England and Wales, BM J, vol.298, issue.6673, pp.555-58, 1989. ,
Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France, J Infect Dis, vol.202, pp.247-50, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02085474
, Avis relatif à la vaccination méningococcique conjugué de sérogroupe C. [Opinion on the meningococcal conjugate vaccine for serogroup C
, , 2009.
Avis relatif à l'antibiothérapie des sujets contacts lors de situations impliquant plusieurs cas d'infection invasive à méningocoque dans une même communauté. [Opinion on the antibiotic therapy for contacts in situations involving several cases of invasive meningococcal disease in a community ,
, , 2012.
, on the prevention of invasive meningococcal disease, Direction Générale de la Santé. Instruction n° DGS/RI1/2011/33 du 27 janvier 2011 relative à la 20. prophylaxie des infections invasives à méningocoque, 2011.